Global Blood Therapeutics, Inc.
FERROPORTIN INHIBITORS AND METHODS OF USE
Last updated:
Abstract:
The subject matter described herein is directed to Ferroportin inhibitor compounds of Formula I and pharmaceutical salts thereof, methods of preparing the compounds, pharmaceutical compositions comprising the compounds and methods of administering the compounds for prophylaxis and/or treatment of diseases caused by a lack of hepcidin or iron metabolism disorders, particularly iron overload states, such as thalassemia, sickle cell disease and hemochromatosis.
Status:
Application
Type:
Utility
Filling date:
12 Dec 2019
Issue date:
18 Jun 2020